These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26844528)

  • 1. Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype.
    Matter MS; Marquardt JU; Andersen JB; Quintavalle C; Korokhov N; Stauffer JK; Kaji K; Decaens T; Quagliata L; Elloumi F; Hoang T; Molinolo A; Conner EA; Weber A; Heikenwalder M; Factor VM; Thorgeirsson SS
    Hepatology; 2016 Jun; 63(6):1888-99. PubMed ID: 26844528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic driver genes and tumor microenvironment determine the type of liver cancer.
    Wang G; Wang Q; Liang N; Xue H; Yang T; Chen X; Qiu Z; Zeng C; Sun T; Yuan W; Liu C; Chen Z; He X
    Cell Death Dis; 2020 May; 11(5):313. PubMed ID: 32366840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumors.
    Stauffer JK; Scarzello AJ; Andersen JB; De Kluyver RL; Back TC; Weiss JM; Thorgeirsson SS; Wiltrout RH
    Cancer Res; 2011 Apr; 71(7):2718-27. PubMed ID: 21324921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
    Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
    Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic β-Catenin, PIK3CA and MET.
    Liu JJ; Li Y; Chen WS; Liang Y; Wang G; Zong M; Kaneko K; Xu R; Karin M; Feng GS
    J Hepatol; 2018 Jul; 69(1):79-88. PubMed ID: 29505847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-catenin deficiency in hepatocytes aggravates hepatocarcinogenesis driven by oncogenic β-catenin and MET.
    Liang Y; Feng Y; Zong M; Wei XF; Lee J; Feng Y; Li H; Yang GS; Wu ZJ; Fu XD; Feng GS
    Hepatology; 2018 May; 67(5):1807-1822. PubMed ID: 29152756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.
    Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
    Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
    Li G; Liu D; Kimchi ET; Kaifi JT; Qi X; Manjunath Y; Liu X; Deering T; Avella DM; Fox T; Rockey DC; Schell TD; Kester M; Staveley-O'Carroll KF
    Gastroenterology; 2018 Mar; 154(4):1024-1036.e9. PubMed ID: 29408569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice.
    Wang C; Yang W; Yan HX; Luo T; Zhang J; Tang L; Wu FQ; Zhang HL; Yu LX; Zheng LY; Li YQ; Dong W; He YQ; Liu Q; Zou SS; Lin Y; Hu L; Li Z; Wu MC; Wang HY
    Hepatology; 2012 Jan; 55(1):108-20. PubMed ID: 21932402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SKP2 cooperates with N-Ras or AKT to induce liver tumor development in mice.
    Delogu S; Wang C; Cigliano A; Utpatel K; Sini M; Longerich T; Waldburger N; Breuhahn K; Jiang L; Ribback S; Dombrowski F; Evert M; Chen X; Calvisi DF
    Oncotarget; 2015 Feb; 6(4):2222-34. PubMed ID: 25537506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocytes promote liver carcinogenesis in an oncogene-specific manner.
    Juric V; Ruffell B; Evason KJ; Hu J; Che L; Wang L; Chen X; Bishop JM
    J Hepatol; 2016 Apr; 64(4):881-90. PubMed ID: 26639397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
    Wehr A; Baeck C; Ulmer F; Gassler N; Hittatiya K; Luedde T; Neumann UP; Trautwein C; Tacke F
    PLoS One; 2014; 9(11):e112327. PubMed ID: 25372401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment of mouse lipogenic inflammation-mediated hepatocarcinoma model by hydrodynamic injection system].
    Lu Y; Yang J; Zhao J; Qin H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Feb; 36(2):122-129. PubMed ID: 32314709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma.
    Shi JY; Yang LX; Wang ZC; Wang LY; Zhou J; Wang XY; Shi GM; Ding ZB; Ke AW; Dai Z; Qiu SJ; Tang QQ; Gao Q; Fan J
    J Pathol; 2015 Mar; 235(4):546-58. PubMed ID: 25255875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways.
    Li H; Zhang J; Lee MJ; Yu GR; Han X; Kim DG
    Oncotarget; 2017 Mar; 8(11):18129-18144. PubMed ID: 28184024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling.
    Borst O; Münzer P; Gatidis S; Schmidt EM; Schönberger T; Schmid E; Towhid ST; Stellos K; Seizer P; May AE; Lang F; Gawaz M
    Circ Res; 2012 Oct; 111(10):1297-307. PubMed ID: 22927331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids.
    Riemer P; Rydenfelt M; Marks M; van Eunen K; Thedieck K; Herrmann BG; Blüthgen N; Sers C; Morkel M
    J Cell Biol; 2017 Jun; 216(6):1567-1577. PubMed ID: 28442534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.